IncellDx Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:IncellDx Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10371
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IncellDx Inc (IncellDx) is a single cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies. The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ transplant rejection. Its products comprise HIV viral reservoirs probes, HIV tropism probes, HCV viral reservoirs probes, EBV viral reservoirs probes, E6 and E7 mRNA kits, E6 and E7 mRNA probes, fixative permeabilization reagents, core reagents, and HPV positive control and HPV negative control products. The company markets its products across Greece, Spain, China, India and the US. IncellDx is headquartered in Menlo Park, California, the US.

IncellDx Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IncellDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IncellDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IncellDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IncellDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
IncellDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
IncellDx Inc, Medical Equipment, Deal Details 10
Venture Financing 10
InCellDx Raises US$4 Million In Venture Financing 10
Partnerships 11
IncellDx Enters into Licensing Agreement with Claremont BioSolutions 11
Celsee Enters into Co-Commercialization Agreement with IncellDx 12
GIMDx Enters into Distribution Agreement with IncellDx 13
Beckman Coulter Life Sciences Enters into Distribution Agreemen with IncellDx 14
InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb 15
IncellDx Inc – Key Competitors 16
IncellDx Inc – Key Employees 17
IncellDx Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Other Significant Developments 19
Jan 17, 2018: Premas, IncellDx Ink India Distribution Agreement 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
IncellDx Inc, Medical Equipment, Key Facts 2
IncellDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
IncellDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IncellDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
IncellDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IncellDx Inc, Deals By Market, 2012 to YTD 2018 8
IncellDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InCellDx Raises US$4 Million In Venture Financing 10
IncellDx Enters into Licensing Agreement with Claremont BioSolutions 11
Celsee Enters into Co-Commercialization Agreement with IncellDx 12
GIMDx Enters into Distribution Agreement with IncellDx 13
Beckman Coulter Life Sciences Enters into Distribution Agreemen with IncellDx 14
InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb 15
IncellDx Inc, Key Competitors 16
IncellDx Inc, Key Employees 17

List of Figures
IncellDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
IncellDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
IncellDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
IncellDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
IncellDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
IncellDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
IncellDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
IncellDx Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[IncellDx Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Venture Life Group Plc (VLG):企業の財務・戦略的SWOT分析
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy …
  • United Bank of India:企業の戦略・SWOT・財務情報
    United Bank of India - Strategy, SWOT and Corporate Finance Report Summary United Bank of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bellvitge Biomedical Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a research centre focused on cellular medicine. It conducts clinical and basic research for developing treatments and techniques to improve health care. IDIBELL carries its research work in the fields of cancer and human molecular genetics …
  • Horizon Discovery Group Plc:企業のM&A・事業提携・投資動向
    Horizon Discovery Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Horizon Discovery Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Concordia International Corp (CXR)-製薬・医療分野:企業M&A・提携分析
    Summary Concordia International Corp (Concordia), formerly Concordia Healthcare Corp is a healthcare products provider that offers orphan drugs. The company undertakes the management and acquisition of legacy pharmaceutical products, orphan drugs and medical devices for diabetics. Its products compr …
  • D.R. Horton, Inc.:企業の戦略・SWOT・財務情報
    D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Thaivivat Insurance Public Company Limited
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Celgene Corp (CELG):製薬・医療:M&Aディール及び事業提携情報
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Rich Products Corporation:企業の戦略・SWOT・財務情報
    Rich Products Corporation - Strategy, SWOT and Corporate Finance Report Summary Rich Products Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • China CAMC Engineering Co Ltd (002051):企業の財務・戦略的SWOT分析
    Summary China CAMC Engineering Co Ltd (CAMC), a subsidiary of China National Machinery Industry Corp, is a construction company that offers engineering, procurement and construction services. The company designs and constructs shipyard, turnkey project in pulp plant, agricultural equipment industria …
  • Xenon Pharmaceuticals Inc (XENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that discovers and develops therapeutics for patients suffering with neurological disorders. The company's pipeline products include XEN1101, XEN901, XEN007 and GDC-0310. It discovers various valid …
  • LHC Group, Inc.:企業のM&A・事業提携・投資動向
    LHC Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LHC Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Sandoz Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sandoz Inc (Sandoz), a division of Novartis AG (Novartis), is a generic pharmaceutical company that develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars. The company also provides intermediary products including active pharmaceutical …
  • Strukton Groep Nv
    Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and ant …
  • MDNA Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test is based on the science of mitochondrial DNA, a tissue-based prostate cancer diagnostics for prostate and other cancers. …
  • Bank Zachodni WBK SA:戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Hartford Financial Services Group, Inc.:戦略・SWOT・企業財務分析
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆